Retrospective, multicentric study to evaluate efficacy and safety of Nimotuzumab in cancer patients

Trial Profile

Retrospective, multicentric study to evaluate efficacy and safety of Nimotuzumab in cancer patients

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2018

At a glance

  • Drugs Nimotuzumab (Primary)
  • Indications Cervical cancer; Glioma; Head and neck cancer; Oesophageal cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Sponsors Biocon
  • Most Recent Events

    • 03 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top